NASDAQ:BLRX - Nasdaq - US09071M2052 - ADR
BIOLINERX LTD-SPONS ADR
NASDAQ:BLRX (1/22/2025, 12:47:52 PM)
0.105
0 (0%)
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -95.25% | ||
ROE | -376.32% | ||
Debt/Equity | 0.55 |
Which stocks are experiencing notable movement on Friday?
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
Unusual volume stocks in Tuesday's session
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
BIOLINERX LTD-SPONS ADR
Modi'in Technology Park, 2 HaMa'ayan Street
Modiin 7177871 IL
CEO: Philip A. Serlin
Employees: 79
Company Website: https://www.biolinerx.com/
Investor Relations: http://ir.biolinerx.com/phoenix.zhtml?c=208785&p=irol-IRHome
Phone: 97286429100
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 15.73 | 298.75B | ||
AMGN | AMGEN INC | 14.21 | 146.80B | ||
GILD | GILEAD SCIENCES INC | 20.9 | 115.38B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 840.73 | 110.42B | ||
REGN | REGENERON PHARMACEUTICALS | 15.13 | 75.53B | ||
ARGX | ARGENX SE - ADR | N/A | 38.51B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.66B | ||
BNTX | BIONTECH SE-ADR | N/A | 27.77B | ||
ONC | BEIGENE LTD-ADR | N/A | 23.27B | ||
NTRA | NATERA INC | N/A | 22.80B | ||
BIIB | BIOGEN INC | 8.73 | 20.78B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.00B |